PDZK1 inhibits the development and progression of renal cell carcinoma by suppression of SHP-1 phosphorylation
Ting Tao(Center for Children), Junqi He(Qingdao University), Qiong Qin(Capital Medical University), Junfang Zheng(Capital Medical University), Qiu-Jun Wang(Harbin Medical University), Duiping Feng(Shanxi Medical University), Xiaomei Yang(University of Maryland, Baltimore), Chenchen Zhao(Pennsylvania State University), Xue‐Hui Shi(Capital Medical University), Zhiqiang Peng(Xian Central Hospital), Wen G. Jiang(Shandong Center for Disease Control and Prevention), H Liu(Shanxi Medical University)
Cited by 49
Related Papers
Application of ProTide Technology to Gemcitabine: A Successful Approach to Overcome the Key Cancer Resistance Mechanisms Leads to a New Agent (NUC-1031) in Clinical Development
|Journal of Medicinal Chemistry|2014|151
T Cell Ig Mucin-3 Promotes Homeostasis of Sepsis by Negatively Regulating the TLR Response
|The Journal of Immunology|2013|142
Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy
|International Journal of Nanomedicine|2021|141
Proteomic Analysis of β1-Adrenergic Receptor Interactions with PDZ Scaffold Proteins
|Journal of Biological Chemistry|2005|134
Characterizing a large outbreak of dengue fever in Guangdong Province, China
|Infectious Diseases of Poverty|2016|128